Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Vazquez

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
Plos One|October 15, 2013
Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherinJuan Manuel Iglesias, Izaskun Beloqui, Francisco Garcia-Garcia, et al.
Investigational New Drugs|December 17, 2010
Evolution of the predictive markers amphiregulin and epiregulin mRNAs during long-term cetuximab treatment of KRAS wild-type tumor cellsCristina Oliveras-Ferraros, Anna Massaguer Vall-Llovera, Dolors Carrion Salip, et al.
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin)Begoña Martin-Castillo, Cristina Oliveras-Ferraros, Alejandro Vazquez-Martin, et al.
International Journal of Oncology|July 29, 2010
Pathway-focused proteomic signatures in HER2-overexpressing breast cancer with a basal-like phenotype: new insights into de novo resistance to trastuzumab (Herceptin)Cristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Begoña Martin-Castilló, et al.
Human Immunology|June 10, 2014
Association of the STAT-6 rs324011 (C2892T) variant but not rs324015 (G2964A), with atopic asthma in a Saudi Arabian populationSaleh Al-Muhsen, Alejandro Vazquez-Tello, Amer Jamhawi, et al.
Advances in Therapy|March 5, 2021
Risk Factors for Postoperative Pacemaker Implantation After Rapid Deployment Aortic Valve Replacement: Results from the RADAR RegistryMiguel Gonzalez-Barbeito, José María Arribas, Alejandro Vazquez, et al.
Circulation|October 13, 2004
Prostaglandin E2--mediated relaxation of the ductus arteriosus: effects of gestational age on g protein-coupled receptor expression, signaling, and vasomotor controlNahid Waleh, Hiroki Kajino, Anne Marilise Marrache, et al.
Biochemical and Biophysical Research Communications|March 16, 2011
Inhibitor of Apoptosis (IAP) survivin is indispensable for survival of HER2 gene-amplified breast cancer cells with primary resistance to HER1/2-targeted therapiesCristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Sílvia Cufí, et al.
Cell Cycle (Georgetown, Tex.)|February 16, 2012
Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cellsAlejandro Vazquez-Martin, Luciano Vellon, Pedro M Quirós, et al.
Breast Cancer Research and Treatment|October 28, 2010
Diagnostic utility of mammaglobin and GCDFP-15 in the identification of primary neuroendocrine carcinomas of the breastEugeni Lopez-Bonet, Maria Carmen Pérez-Martínez, Begoña Martin-Castillo, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Plos One|October 15, 2013
Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherinJuan Manuel Iglesias, Izaskun Beloqui, Francisco Garcia-Garcia, et al.
Investigational New Drugs|December 17, 2010
Evolution of the predictive markers amphiregulin and epiregulin mRNAs during long-term cetuximab treatment of KRAS wild-type tumor cellsCristina Oliveras-Ferraros, Anna Massaguer Vall-Llovera, Dolors Carrion Salip, et al.
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin)Begoña Martin-Castillo, Cristina Oliveras-Ferraros, Alejandro Vazquez-Martin, et al.
International Journal of Oncology|July 29, 2010
Pathway-focused proteomic signatures in HER2-overexpressing breast cancer with a basal-like phenotype: new insights into de novo resistance to trastuzumab (Herceptin)Cristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Begoña Martin-Castilló, et al.
Human Immunology|June 10, 2014
Association of the STAT-6 rs324011 (C2892T) variant but not rs324015 (G2964A), with atopic asthma in a Saudi Arabian populationSaleh Al-Muhsen, Alejandro Vazquez-Tello, Amer Jamhawi, et al.
Advances in Therapy|March 5, 2021
Risk Factors for Postoperative Pacemaker Implantation After Rapid Deployment Aortic Valve Replacement: Results from the RADAR RegistryMiguel Gonzalez-Barbeito, José María Arribas, Alejandro Vazquez, et al.
Circulation|October 13, 2004
Prostaglandin E2--mediated relaxation of the ductus arteriosus: effects of gestational age on g protein-coupled receptor expression, signaling, and vasomotor controlNahid Waleh, Hiroki Kajino, Anne Marilise Marrache, et al.
Biochemical and Biophysical Research Communications|March 16, 2011
Inhibitor of Apoptosis (IAP) survivin is indispensable for survival of HER2 gene-amplified breast cancer cells with primary resistance to HER1/2-targeted therapiesCristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Sílvia Cufí, et al.
Cell Cycle (Georgetown, Tex.)|February 16, 2012
Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cellsAlejandro Vazquez-Martin, Luciano Vellon, Pedro M Quirós, et al.
Breast Cancer Research and Treatment|October 28, 2010
Diagnostic utility of mammaglobin and GCDFP-15 in the identification of primary neuroendocrine carcinomas of the breastEugeni Lopez-Bonet, Maria Carmen Pérez-Martínez, Begoña Martin-Castillo, et al.
Pageof 18